France / Germany Production Alliance Falters; Sanofi Vaccine Enters Phase III Trials; Valneva Still in the Vaccine Race
The latest news from French pharma, including why President Emmanuel Macron’s initiative to bring medical…
Pfizer-Wyeth France
Last updated: 14.07.2021
Company description
The Pfizer group has been established for over 50 years in France.
More than 3 000 employees who work daily in the various activities of the company, serving healthcare professionals and patients.
Clinical research: more than 80 physicians, pharmacists, scientists and technicians at the company headquarters in Paris and in different regions of France, ensure the proper conduct of clinical trials initiated by Pfizer
Production: 3 sites in the Val de Loire Alsace and Brittany, the Group’s employees contribute to Pfizer Manufacturing
Pharmaceutical Operations • Human health: employees with headquarters in Paris and visiting medical teams throughout the country. Pfizer is the first drug maker in the world and second in the French market
Products and services
Cardiology
Pain
Endocrinology
Infectious disease
Ophthalmology
Oncology
Pulmonology
Rheumatology
Central Nervous System
Urology
Contact:
Address: 23-25 avenue du Dr. Lannelongue 75668 Paris Cedex 14,France
Tel: +33 (0)1 58 07 30 00
Related
COVID-19 Vaccines / Valneva: A Success Story for France?
While Big Pharma companies like Pfizer, Janssen and AstraZeneca, have grabbed the headlines over the past year for…
France / ‘Humiliation’ & the Sanofi-Pfizer Vaccine Deal; AntiVax Struggles; Servier’s Neurology Push
The latest from French pharma where Sanofi has inked a deal to produce 125 million doses of Pfizer’s COVID-19…
France / Mid-2021 for Sanofi COVID-19 Vaccine; 1 Million Domestic Cases; Ipsen Growth
A roundup of the latest stories from French pharma, including the progress of Sanofi’s COVID-19 vaccine, how…
News Roundup / French Pharma August 2020
A roundup of some of the latest from French pharma, including Sanofi’s bumper Prinicipia deal, how Unither’s…
M&A / Sanofi Buys Principia for USD 3.7 Billion as Part of Specialty Pivot
Sanofi has agreed a deal to buy out its partner, US biotech company Principia Biopharma for USD 3.7 billion in…
Sanofi / Thomas Triomphe Appointed Executive Vice President of Vaccines Unit
With former head David Loew moving to the CEO position at Ipsen, Sanofi appointed French national Thomas Triomphe…
Mid-Cap Strategies / LFB USA CEO Optimistic on Hemophilia Launches Amid COVID Crisis
French firm LFB is targeting the lucrative US market with its hemophilia products and recently received two FDA…
Sanofi / USD 679 Million Investment in French Vaccine Manufacturing
French pharma giant Sanofi is pivoting its focus to invest more heavily in vaccines with a plan to invest USD 679…
Ipsen / New CEO as David Loew Makes Switch From Sanofi Pasteur
David Loew, formerly executive vice president of Sanofi Pasteur, Sanofi’s vaccines division, was appointed…
Europe / A New Approach to Health Crises in France & Germany
Emmanuel Macron and Angela Merkel recently put their heads together to come up with a health strategy that would…
COVID-19 Vaccine / Sanofi CEO Paul Hudson Commits to "Bring a Solution to Everybody, Everywhere"
In a recent interview with Financial Times, Sanofi CEO Paul Hudson set out to clarify some recent comments that the…
